Medacta Group H1 2026 revenue and margin growth; guidance confirmed
H1 2026 revenue rose 9.7% in constant currency; adjusted EBITDA margin was 27.8%. Net profit was EUR 41.9m, impacted by last year’s one-off gain. Guidance for double-digit growth and margin expansion is confirmed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.